Project/Area Number |
15109006
|
Research Category |
Grant-in-Aid for Scientific Research (S)
|
Allocation Type | Single-year Grants |
Research Field |
Gastroenterology
|
Research Institution | Osaka University |
Principal Investigator |
HAYASHI Norio Osaka University, Graduate School of Medicine, Professor (00144478)
|
Co-Investigator(Kenkyū-buntansha) |
TAKEHARA Tetsuo Osaka University, Graduate School of Medicine, Associate Professor (70335355)
KANTO Tatsuya Osaka University, Graduate School of Medicine, Endowed Chair Associate Professor (80372613)
HIRAMTSU Naoki Osaka University, Graduate School of Medicine, Assistant Professor (30362700)
中西 文彦 大阪大学, 医学部附属病院, 医員(臨床研究)
|
Project Period (FY) |
2003 – 2007
|
Project Status |
Completed (Fiscal Year 2007)
|
Budget Amount *help |
¥112,710,000 (Direct Cost: ¥86,700,000、Indirect Cost: ¥26,010,000)
Fiscal Year 2007: ¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2006: ¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2005: ¥23,400,000 (Direct Cost: ¥18,000,000、Indirect Cost: ¥5,400,000)
Fiscal Year 2004: ¥24,570,000 (Direct Cost: ¥18,900,000、Indirect Cost: ¥5,670,000)
Fiscal Year 2003: ¥29,640,000 (Direct Cost: ¥22,800,000、Indirect Cost: ¥6,840,000)
|
Keywords | chronic hepatitis C / hepatocellular carcinoma / dendritic cell / natural killer cell / innate immuni / NK receptor / Toll-like receptor / RIG-I / RIG-I / インターフェロン / regulatory T細胞 / ペグインターフェロン / リバビリン / 持続ALT正常 / FoxP3 / IL-10 / Th1 / 免疫 / blood DC / 先天免疫 / 獲得免疫 / MICA / B / サブセット / Pseudo-HCV / IFNα / IL-15 |
Research Abstract |
Sequential activation of innate and adaptive immune response is crucial for virus elimination. Dendritic cells (DCs) sense virus infection via toll-like receptors (TLR) or retinoic acid inducible gene-I (RIG-I), resulting in the secretion of type-I interferons (IFN) and inflammatory cytokines. Blood DC consist of two subsets; myeloid DC (MDC) and plasmacytoid DC (PDC). In chronic hepatitis C patients, both of these DC subsets decreased compared to healthy subjects. Furthermore, MDC and PDC are functionally impaired in HCV-infected patients in the ability to stimulate T cell proliferation as well as cytokine secretion. In MDC from HCV-infected patients, regardless of higher expression of TLR2, TLR4 and RIG-I compared to the controls, the levels of TLR/RIG-I-mediated IFN-β, TNF-α or IL-12p70 induction are lower than those in uninfected donors. These results suggest that the signal transduction in the downstream of TLR/RIG-I in DC is profoundly impaired in HCV infection. In order to searc
… More
h for the mechanisms of above-mentioned DC malfunction in HCV infection, we inoculated pseudo-HCV particles, covered by chimeric HCV E1/E2 protein, to MDC or PDC recovered from healthy donors. Pseudo-HCV enters only MDC but not PDC, suggesting that HCV aims to infect myeloid subsets. However, unanswered question still remains for the mechanisms of HCV-induced PDC dysfunction. Cumulative reports have been published for pervasive impairment in adaptive immune system in HCV infection, such as virus-specific CD4^+ or CD8^+ T cells. Naturally occurring regulatory T cells (Tregs) are specialized T cell subsets that are capable of suppressing auto-reactive T cells. In order to clarify the roles of Treg in chronic HCV infection, we compared the frequency and function of Tregs between the patients and uninfected donors. Peripheral Tregs in chronic HCV infection is greater in frequency and in suppressive ability than those in healthy counterparts, much more in patients with persistently normal ALT levels compared to those with active hepatitis. These results imply that the abundance of Treg is beneficial for the maintenance of low-grade liver inflammation, possibly by suppressing inflammatory Th1 cells. In conclusion, active and reciprocal interactions among innate and adaptive immune cells, which are orchestrated by DC, are critical in shaping immuno-pathogenesis of HCV infection. Less
|